研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

PD-1 信号传导限制磷脂磷酸酶 1 的表达并促进瘤内 CD8 T 细胞铁死亡。

PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis.

发表日期:2024 Aug 22
作者: Yu Ping, Jiqi Shan, Haiming Qin, Feng Li, Jiao Qu, Ru Guo, Dong Han, Wei Jing, Yaqing Liu, Jinyan Liu, Zhangnan Liu, Jieyao Li, Dongli Yue, Feng Wang, Liping Wang, Bin Zhang, Bo Huang, Yi Zhang
来源: IMMUNITY

摘要:

肿瘤微环境(TME)促进免疫细胞的代谢重编程和功能障碍。在这里,我们研究了 TME 对 CD8 T 细胞磷脂代谢的影响。在肺癌中,瘤内 CD8 T 细胞中的磷脂酰胆碱 (PC) 和磷脂酰乙醇胺 (PE) 低于循环 CD8 T 细胞。瘤内 CD8 T 细胞表现出催化 PE 和 PC 合成的磷脂磷酸酶 1 (PLPP1) 表达减少。 T 细胞特异性删除 Plpp1 会损害抗肿瘤免疫并促进 T 细胞因铁死亡而死亡。 TME 中的不饱和脂肪酸刺激 Plpp1-/- CD8 T 细胞的铁死亡。从机制上讲,CD8 T 细胞中的程序性死亡 1 (PD-1) 信号传导诱导 GATA1 与启动子区域 Plpp1 结合,从而抑制 Plpp1 表达。 PD-1 阻断增加了 Plpp1 表达并恢复了 CD8 T 细胞抗肿瘤功能,但不能挽救 Plpp1-/- CD8 T 细胞功能障碍。因此,PD-1 信号传导调节 CD8 T 细胞中的磷脂代谢,对免疫疗法具有治疗意义。版权所有 © 2024 Elsevier Inc. 保留所有权利。
The tumor microenvironment (TME) promotes metabolic reprogramming and dysfunction in immune cells. Here, we examined the impact of the TME on phospholipid metabolism in CD8+ T cells. In lung cancer, phosphatidylcholine (PC) and phosphatidylethanolamine (PE) were lower in intratumoral CD8+ T cells than in circulating CD8+ T cells. Intratumoral CD8+ T cells exhibited decreased expression of phospholipid phosphatase 1 (PLPP1), which catalyzes PE and PC synthesis. T cell-specific deletion of Plpp1 impaired antitumor immunity and promoted T cell death by ferroptosis. Unsaturated fatty acids in the TME stimulated ferroptosis of Plpp1-/- CD8+ T cells. Mechanistically, programmed death-1 (PD-1) signaling in CD8+ T cells induced GATA1 binding to the promoter region Plpp1 and thereby suppressed Plpp1 expression. PD-1 blockade increased Plpp1 expression and restored CD8+ T cell antitumor function but did not rescue dysfunction of Plpp1-/- CD8+ T cells. Thus, PD-1 signaling regulates phospholipid metabolism in CD8+ T cells, with therapeutic implications for immunotherapy.Copyright © 2024 Elsevier Inc. All rights reserved.